Pharmaceutical sector focus
Kluwer IP Law is a partner to Intellectual Property Law professionals in the Pharma Sector worldwide. We support your peers through rich insights presented via a wide range of sources such as those described below
Manual of Industrial Property ("Brown Book")
The Brown Book: our flagship publication and key resource for IP professionals to locate fee data; Its exhaustive contents include:
- Separate chapters, in alphabetical order, for nearly 200 countries and several regional industrial property protection systems
- Full text of the most important conventions, treaties and agreements (including the Paris Convention, the Patent Cooperation Treaty, and the Madrid Agreement)
- A section on the European Patent System, describing the European Patent Convention and its implementing regulations
Extract following information, inter alia, on Patents, Trademarks and Designs, for Pharma Specialists:
- Annuities and Fees from several jurisdictions in one overview
- Kinds of Patents available
- Duration of protection
- Second Use
- Treatment of the human body
- What may be patented
- Biological materials
- Requirements for filing application
- Rights of prior use
- Infringement
- Assignment
Guide to EU Pharmaceutical Law, 7th Edition
This publication addresses the life cycle of a medicinal product & medical device, from development to clinical trials to product launch and ongoing pharmacovigilance, including information on:
- Generic products and ‘essential similarity’,
- Paediatric use and the requisite additional trials,
- Biologicals and ‘biosimilars’,
- Homeopathic and herbal medicines,
- Relevant competition law and IP rights,
- Obtaining a marketing authorisation,
- Criteria for conditional marketing authorisations,
- Parallel Trade,
- Reporting procedures
Comparison of jurisdictions in relation to Patent Protection for Second Medical Uses
This text explains the key jurisdictional (19) differences and challenges in protecting and enforcing second medical use (SMU) claims, where each chapter considers such issues and topics as the following:
- Availability of protection,
- Validity of claims
- Scope of protection,
- Enforcement, and
- Infringement and investigations of SMU claims
This publication provides a detailed country-by-country analysis by focusing on specific issues and national peculiarities that deviate from the European Patent Office (EPO) practice
Competition and Patent Law in the Pharmaceutical Sector: An International Perspective
Examines the approaches to competition and IP regulation:
- In 14 leading jurisdictions (Brazil, Canada, China, France, Germany, Greece, India, Italy, Japan, the Netherlands, Russia, South Africa, the United Kingdom, and the United States),
- Patent lifecycle strategies
- Abusive litigation
- Damages for patents and antitrust infringement
International Licensing and Technology Transfer
Single-source commentary on licensing in an international context, which includes:
- Commentary on specific clauses, both non-jurisdiction specific and on a country-by-country basis,
- Sample patent license clauses
- Methods for determining or reliably estimating the value of the intellectual property being licensed.
Kluwer IP Case Law
Search within several sets of cases:
- 1.700+ Key decisions from EU and US jurisdictions in English
- 36.000 Cases, including the EPO case law database
- IP rules, laws and procedures for 230+ jurisdictions
Stay up-to-date, be aware
- www.KluwerPatentBlog.com helping IP professionals keep abreast of developments in their area of expertise
- Bi-weekly e-mail newsletter containing all important IP recent development by country and by topic
- Special focus area with UPC and Brexit updates
